Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.88
(
1.05%
)
US TECH 100
26,239.98
(
1.81%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
96.71
(
1.78%
)
Bitcoin
78,630.37
(
3.02%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: microcapfun post# 55238

Sunday, 11/25/2007 9:01:40 PM

Sunday, November 25, 2007 9:01:40 PM

Post# of 257437
My own ophthalmologist raves about the ReStor lens from Alcon. It’s a technological marvel, but there has been substantial pushback from managed care regarding the premium price. As a result, its market share among all IOL’s remains stuck in the mid single digits. Regards, Dew

p.s. Do you have any further comments re #msg-24682767 (diminishing returns in drug discovery)?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today